Williams Jones & Associates’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$219K Sell
937
-720
-43% -$166K ﹤0.01% 353
2019
Q1
$392K Sell
1,657
-30
-2% -$9.45K 0.01% 299
2018
Q4
$508K Buy
1,687
+371
+28% +$118K 0.01% 253
2018
Q3
$465K Buy
1,316
+25
+2% +$8.61K 0.01% 309
2018
Q2
$375K Sell
1,291
-6,855
-84% -$1.93M 0.01% 321
2018
Q1
$2.23M Sell
8,146
-2,835
-26% -$880K 0.05% 168
2017
Q4
$3.5M Buy
10,981
+474
+5% +$152K 0.08% 148
2017
Q3
$3.29M Buy
10,507
+4,431
+73% +$1.31M 0.08% 149
2017
Q2
$1.65M Sell
6,076
-897
-13% -$237K 0.04% 193
2017
Q1
$1.91M Buy
6,973
+679
+11% +$192K 0.05% 182
2016
Q4
$1.78M Buy
6,294
+298
+5% +$88.3K 0.05% 181
2016
Q3
$1.88M Sell
5,996
-181
-3% -$53.6K 0.05% 170
2016
Q2
$1.49M Sell
6,177
-1,720
-22% -$453K 0.05% 171
2016
Q1
$2.06M Buy
7,897
+138
+2% +$36.5K 0.1% 127
2015
Q4
$2.38M Sell
7,759
-857
-10% -$246K 0.11% 118
2015
Q3
$2.51M Sell
8,616
-19,388
-69% -$6.4M 0.11% 127
2015
Q2
$11.3M Buy
28,004
+11,895
+74% +$4.77M 0.43% 65
2015
Q1
$6.8M Sell
16,109
-27
-0.2% -$10.6K 0.27% 98
2014
Q4
$5.48M Buy
+16,136
New +$5.22M 0.22% 105

Other funds holding BIIB

Williams Jones & Associates's BIIB Position: Q2 2019 in Review

Williams Jones & Associates reduced its Biogen (BIIB) stake by 43% in Q2 2019, selling an estimated $166K and leaving 937 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #353.

Williams Jones & Associates first reported a position in BIIB in Q4 2014 and has held it in 19 quarters since. The position peaked at $11.3M in Q2 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Williams Jones & Associates held 937 shares of Biogen worth $219K as of Q2 2019.
  • Williams Jones & Associates sold 720 Biogen shares in Q2 2019, an estimated $166K.
  • Biogen made up ﹤0.01% of Williams Jones & Associates's portfolio in Q2 2019, its #353 holding.
  • Williams Jones & Associates first reported a position in Biogen in Q4 2014 and has held it in 19 quarters since.
  • Williams Jones & Associates's Biogen position peaked at $11.3M in Q2 2015.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.